Tiwari H, Saha S, Ghosh M
J Cell Biochem. 2024; 126(1):e30684.
PMID: 39655425
PMC: 11735889.
DOI: 10.1002/jcb.30684.
Sanhueza C, Vergara D, Chavez-Aravena C, Galvez-Jiron F, Chavez-Angel E, Castro-Alvarez A
Pharmaceuticals (Basel). 2023; 16(10).
PMID: 37895899
PMC: 10609949.
DOI: 10.3390/ph16101428.
Alkan S, Serhat Sahinoglu M, Cinpolat H
Oman Med J. 2023; 38(3):e502.
PMID: 37464988
PMC: 10351212.
DOI: 10.5001/omj.2023.71.
Mourenza A, Lorente-Torres B, Durante E, Llano-Verdeja J, Aparicio J, Fernandez-Lopez A
Antibiotics (Basel). 2022; 11(3).
PMID: 35326819
PMC: 8944844.
DOI: 10.3390/antibiotics11030356.
Zhu T, Liu H, Su L, Dawood A, Hu C, Chen X
Int J Mol Sci. 2022; 23(1).
PMID: 35008808
PMC: 8745702.
DOI: 10.3390/ijms23010382.
Overexpression of microRNA-340-5p Ameliorates Inflammatory Response and Intracellular Survival of in Alveolar Type II Cells.
Zhang B, Li H, Zhang J, Hang Y, Xu Y
Infect Drug Resist. 2021; 14:1573-1584.
PMID: 33911883
PMC: 8071707.
DOI: 10.2147/IDR.S291867.
MicroRNA-30e-5p Regulates SOCS1 and SOCS3 During Bacterial Infection.
Mishra R, Krishnamoorthy P, Kumar H
Front Cell Infect Microbiol. 2021; 10:604016.
PMID: 33585275
PMC: 7873556.
DOI: 10.3389/fcimb.2020.604016.
Trained Immunity for Personalized Cancer Immunotherapy: Current Knowledge and Future Opportunities.
Lerias J, de Sousa E, Paraschoudi G, Martins J, Condeco C, Figueiredo N
Front Microbiol. 2020; 10:2924.
PMID: 31998254
PMC: 6967396.
DOI: 10.3389/fmicb.2019.02924.
Therapeutic host-directed strategies to improve outcome in tuberculosis.
Young C, Walzl G, Du Plessis N
Mucosal Immunol. 2019; 13(2):190-204.
PMID: 31772320
PMC: 7039813.
DOI: 10.1038/s41385-019-0226-5.
Immunometabolism and Pulmonary Infections: Implications for Protective Immune Responses and Host-Directed Therapies.
Rao M, Dodoo E, Zumla A, Maeurer M
Front Microbiol. 2019; 10:962.
PMID: 31134013
PMC: 6514247.
DOI: 10.3389/fmicb.2019.00962.
MicroRNA-27a controls the intracellular survival of Mycobacterium tuberculosis by regulating calcium-associated autophagy.
Liu F, Chen J, Wang P, Li H, Zhou Y, Liu H
Nat Commun. 2018; 9(1):4295.
PMID: 30327467
PMC: 6191460.
DOI: 10.1038/s41467-018-06836-4.
Translational Potential of Therapeutics Targeting Regulatory Myeloid Cells in Tuberculosis.
Plessis N, Kotze L, Leukes V, Walzl G
Front Cell Infect Microbiol. 2018; 8:332.
PMID: 30298121
PMC: 6160538.
DOI: 10.3389/fcimb.2018.00332.
Host-targeted therapy for tuberculosis: Time to revisit the concept.
Desikan P, Rangnekar A
Indian J Med Res. 2018; 147(3):233-238.
PMID: 29923511
PMC: 6022386.
DOI: 10.4103/ijmr.IJMR_652_17.
Mycobacterium tuberculosis Exploits a Molecular Off Switch of the Immune System for Intracellular Survival.
von Both U, Berk M, Agapow P, Wright J, Git A, Hamilton M
Sci Rep. 2018; 8(1):661.
PMID: 29330469
PMC: 5766484.
DOI: 10.1038/s41598-017-18528-y.
A review of clinical models for the evaluation of human TB vaccines.
OShea M, McShane H
Hum Vaccin Immunother. 2016; 12(5):1177-87.
PMID: 26810964
PMC: 4963076.
DOI: 10.1080/21645515.2015.1134407.
Host-directed drug therapy for tuberculosis.
Guler R, Brombacher F
Nat Chem Biol. 2015; 11(10):748-51.
PMID: 26379013
DOI: 10.1038/nchembio.1917.
Targeting Batf2 for infectious diseases and cancer.
Guler R, Roy S, Suzuki H, Brombacher F
Oncotarget. 2015; 6(29):26575-82.
PMID: 26376615
PMC: 4694937.
DOI: 10.18632/oncotarget.5576.
The association between serum miR-155 and natural killer cells from tuberculosis patients.
Zhang C, Xi X, Wang Q, Jiao J, Zhang L, Zhao H
Int J Clin Exp Med. 2015; 8(6):9168-72.
PMID: 26309574
PMC: 4538006.
Host-Directed Therapies for Tuberculosis.
Tobin D
Cold Spring Harb Perspect Med. 2015; 5(10).
PMID: 25986592
PMC: 4588138.
DOI: 10.1101/cshperspect.a021196.
High serum miR-183 level is associated with the bioactivity of macrophage derived from tuberculosis patients.
Zhang C, Wang Q, Xi X, Jiao J, Xu W, Huang J
Int J Clin Exp Pathol. 2015; 8(1):655-9.
PMID: 25755759
PMC: 4348860.